Requirement of the MRN complex for ATM activation by DNA damageTamar Uziel(AbbVie (United States)), Yosef Shiloh(Tel Aviv University)The EMBO JournalOctober 7, 200310.1093/emboj/cdg541Cited by 1,053SaveCiteExport RISWatch citationsRelated PapersDiscovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours|Nature|2017|853Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer|Nature|2020|404Beyond ATM: The protein kinase landscape of the DNA damage response|FEBS Letters|2011|207UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors|Cell|2019|126Phosphoproteomics reveals novel modes of function and inter‐relationships among PIKKs in response to genotoxic stress|The EMBO Journal|2020|48